Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 5 | 5 | 5 | 37 | 362 |
| Gross Profit | 5 | 5 | 5 | 37 | 362 |
| Operating Expenses | 24,772 | 26,750 | 26,799 | 33,660 | 22,902 |
| Operating Income | -24,767 | -26,745 | -26,794 | -33,623 | -22,540 |
| Interest Expense | 6 | -1 | 1 | 6 | 29 |
| Other Income | 1,928 | 2,104 | 2,401 | 1,988 | 1,898 |
| Pre-tax Income | -22,845 | -24,640 | -24,394 | -31,641 | -20,671 |
| Net Income Continuous | -22,845 | -24,640 | -24,394 | -31,641 | -20,671 |
| Net Income | $-22,845 | $-24,640 | $-24,394 | $-31,641 | $-20,671 |
| EPS Basic Total Ops | -0.32 | -0.35 | -0.34 | -0.55 | -0.39 |
| EPS Basic Continuous Ops | -0.32 | -0.35 | -0.34 | -0.56 | -0.39 |
| EPS Diluted Total Ops | -0.32 | -0.35 | -0.34 | -0.55 | -0.39 |
| EPS Diluted Continuous Ops | -0.32 | -0.35 | -0.34 | -0.56 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.35 | -0.34 | -0.33 | -0.39 |
| EBITDA(a) | $-25,709 | $-27,753 | $-27,670 | $-34,204 | $-23,092 |